{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:03:01Z","timestamp":1788778981668,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This review provides updates in the evaluation and management of key dermatologic diseases encountered in the hospitalized child.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Our understanding of dermatologic disorders in children continues to evolve. Staphylococcal scalded skin syndrome (SSSS) is a potentially severe blistering disorder typically seen in children under the age of 4 with an incidence that is increasing in the United States. Recent research has highlighted that the majority of cases are due to methicillin-sensitive <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> (MSSA) and most patients can be adequately managed with beta-lactams. Toxic epidermal necrolysis (TEN) is one of the most feared dermatologic disorders. Currently, there is a lack of consensus on the most efficacious first-line systemic therapy. Etanercept is increasingly being used based on studies showing a shorter time to re-epithelization and decreased mortality. Lastly, the COVID-19 pandemic introduced the novel inflammatory condition multisystem inflammatory syndrome in children (MIS-C) in which approximately three out of four children present with a mucocutaneous eruption. Early recognition of the dermatologic features of MIS-C is important in potentially establishing a diagnosis and differentiating it from the many other causes of childhood fever and rash.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>There are no clear universal treatment guidelines for these rare diagnoses, and therefore, clinicians must remain informed of the latest findings in diagnosis and therapeutics.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001258","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T11:39:59Z","timestamp":1682422799000},"page":"460-466","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Evolving trends in inpatient paediatric dermatology"],"prefix":"10.1097","volume":"35","author":[{"given":"Juliana","family":"Pineider","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash S.","family":"Oza","sequence":"additional","affiliation":[{"name":"The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah D.","family":"Cipriano","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Utah Health, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/pde.13549","article-title":"Inpatient burden of pediatric dermatology in the United States","volume":"35","author":"Arnold","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12519-018-0150-x","article-title":"Staphylococcal-scalded skin syndrome: evaluation, diagnosis, and management","volume":"14","author":"Leung","year":"2018","journal-title":"World J Pediatr"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/bjd.16097","article-title":"Epidemiology of staphylococcal scalded skin syndrome in US children","volume":"178","author":"Staiman","year":"2018","journal-title":"Br J Dermatol"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1542\/hpeds.2018-0032","article-title":"Variation in diagnostic test use and associated outcomes in staphylococcal scalded skin syndrome at children's hospitals","volume":"8","author":"Neubauer","year":"2018","journal-title":"Hosp Pediatr"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/jdv.12541","article-title":"Staphylococcal scalded skin syndrome: diagnosis and management in children and adults","volume":"28","author":"Handler","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/pde.15102","article-title":"Staphylococcal scalded skin syndrome: clinical features, ancillary testing, and patient management","volume":"39","author":"Gray","year":"2022","journal-title":"Pediatr Dermatol"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/pde.14470","article-title":"Staphylococcal scalded skin syndrome: an epidemiological and clinical review of 84 cases","volume":"38","author":"Liy-Wong","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/pde.14014","article-title":"Antibiotic sensitivity and clinical outcomes in staphylococcal scalded skin syndrome","volume":"37","author":"Wang","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/1346-8138.16476","article-title":"Clinical features and outcomes in children with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"49","author":"Chi","year":"2022","journal-title":"J Dermatol"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/INF.0000000000001571","article-title":"Fever in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in pediatric cases: laboratory work-up and antibiotic therapy","volume":"36","author":"Paulmann","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaad.2016.12.024","article-title":"Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States","volume":"76","author":"Hsu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/pde.13383","article-title":"Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"35","author":"Antoon","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/pde.15047","article-title":"Infantile Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review of clinical features and outcomes in children ages 12\u200amonths and under","volume":"39","author":"Iriarte","year":"2022","journal-title":"Pediatr Dermatol"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/bjd.20063","article-title":"Blistering severe cutaneous adverse reactions in children: proposal for pediatric-focused clinical criteria","volume":"185","author":"Ramien","year":"2021","journal-title":"Br J Dermatol"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/jamadermatol.2019.3589","article-title":"Mucocutaneous eruptions in acutely ill pediatric patients: think of Mycoplasma pneumoniae (and Other Infections) first","volume":"156","author":"Ramien","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaip.2021.09.014","article-title":"Deep neural network for early image diagnosis of Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"10","author":"Fujimoto","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ijd.16561","article-title":"A comparison of international treatment guidelines for Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"62","author":"Pisano","year":"2023","journal-title":"Int J Dermatol"},{"key":"R19-20250730","first-page":"CD013130","article-title":"Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS\/TEN overlap syndrome","volume":"11","author":"Jacobsen","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.anai.2022.05.009","article-title":"Etanercept treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"129","author":"Tian","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jaip.2022.01.038","article-title":"Evaluation of combination therapy with etanercept and systemic corticosteroids for Stevens-Johnson syndrome and toxic epidermal necrolysis: a multicenter observational study","volume":"10","author":"Zhang","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/pde.14179","article-title":"Levetiracetam-induced pediatric toxic epidermal necrolysis successfully treated with etanercept","volume":"37","author":"Est\u00e9banez","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/ijd.15054","article-title":"Intensive care needs and long-term outcome of pediatric toxic epidermal necrolysis: a 10-year experience","volume":"60","author":"Williams","year":"2021","journal-title":"Int J Dermatol"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/jamadermatol.2021.1136","article-title":"Long-term physical and psychological outcomes of Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"157","author":"Hoffman","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1001\/jama.2022.8025","article-title":"Severity and incidence of multisystem inflammatory syndrome in children during 3 SARS-CoV-2 pandemic waves in Israel","volume":"327","author":"Levy","year":"2022","journal-title":"JAMA"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.2021.2091","article-title":"Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19","volume":"325","author":"Feldstein","year":"2021","journal-title":"JAMA"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in US children and adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"e163235","DOI":"10.1172\/JCI163235","article-title":"The Notch1\/CD22 signaling axis disrupts Treg function in SARS-CoV-2\u2013associated multisystem inflammatory syndrome in children","volume":"3","author":"Benamar","year":"2023","journal-title":"J Clin Invest"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7104a1","article-title":"Council of State and Territorial Epidemiologists\/CDC Surveillance Case Definition for multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection: United States","volume":"71","author":"Melgar","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jamadermatol.2020.4779","article-title":"Mucocutaneous manifestations of multisystem inflammatory syndrome in children during the COVID-19 pandemic","volume":"157","author":"Young","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R31-20250730","doi-asserted-by":"crossref","DOI":"10.1111\/pde.15233","article-title":"Cutaneous presentation of bullous multisystem inflammatory syndrome in a child: a diagnosis not to \u2018MIS-C\u2019","author":"El-Hamdi","year":"2023","journal-title":"Pediatr Dermatol"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S2352-4642(21)00050-X","article-title":"Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study","volume":"5","author":"Abrams","year":"2021","journal-title":"Lancet Child Adolesc Health"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:02:45Z","timestamp":1753898565000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001258","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]}}}